220 related articles for article (PubMed ID: 20214410)
1. Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.
Peeters MY; Allegaert K; Blussé van Oud-Alblas HJ; Cella M; Tibboel D; Danhof M; Knibbe CA
Clin Pharmacokinet; 2010 Apr; 49(4):269-75. PubMed ID: 20214410
[TBL] [Abstract][Full Text] [Related]
2. A bodyweight-dependent allometric exponent for scaling clearance across the human life-span.
Wang C; Peeters MY; Allegaert K; Blussé van Oud-Alblas HJ; Krekels EH; Tibboel D; Danhof M; Knibbe CA
Pharm Res; 2012 Jun; 29(6):1570-81. PubMed ID: 22287046
[TBL] [Abstract][Full Text] [Related]
3. The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.
Wang C; Allegaert K; Peeters MY; Tibboel D; Danhof M; Knibbe CA
Br J Clin Pharmacol; 2014 Jan; 77(1):149-59. PubMed ID: 23772816
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sigmoidal maturation and allometric models: prediction of propofol clearance in neonates and infants.
Mahmood I
Am J Ther; 2013 Jan; 20(1):21-8. PubMed ID: 23299229
[TBL] [Abstract][Full Text] [Related]
5. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
[TBL] [Abstract][Full Text] [Related]
6. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults.
Tegenge MA; Mahmood I
Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085
[TBL] [Abstract][Full Text] [Related]
7. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.
Mahmood I
Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882
[TBL] [Abstract][Full Text] [Related]
8. Maturational pharmacokinetics of single intravenous bolus of propofol.
Allegaert K; de Hoon J; Verbesselt R; Naulaers G; Murat I
Paediatr Anaesth; 2007 Nov; 17(11):1028-34. PubMed ID: 17897267
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?
Mahmood I
Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
Mahmood I
J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
[TBL] [Abstract][Full Text] [Related]
11. Pediatric models for adult target-controlled infusion pumps.
Anderson BJ
Paediatr Anaesth; 2010 Mar; 20(3):223-32. PubMed ID: 19627530
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents.
Mahmood I; Tegenge MA
J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373
[TBL] [Abstract][Full Text] [Related]
13. Prediction of drug clearance in children: an evaluation of the predictive performance of several models.
Mahmood I; Staschen CM; Goteti K
AAPS J; 2014 Nov; 16(6):1334-43. PubMed ID: 25274608
[TBL] [Abstract][Full Text] [Related]
14. Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults.
Mahmood I
Drugs R D; 2020 Mar; 20(1):1-10. PubMed ID: 31820365
[TBL] [Abstract][Full Text] [Related]
15. A general purpose pharmacokinetic model for propofol.
Eleveld DJ; Proost JH; Cortínez LI; Absalom AR; Struys MM
Anesth Analg; 2014 Jun; 118(6):1221-37. PubMed ID: 24722258
[TBL] [Abstract][Full Text] [Related]
16. Allometric extrapolation of factors VII, VIII and IX clearance in children from adults.
Mahmood I
J Thromb Haemost; 2012 Aug; 10(8):1609-13. PubMed ID: 22612736
[TBL] [Abstract][Full Text] [Related]
17. A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults.
Ince I; de Wildt SN; Wang C; Peeters MY; Burggraaf J; Jacqz-Aigrain E; van den Anker JN; Tibboel D; Danhof M; Knibbe CA
Clin Pharmacokinet; 2013 Jul; 52(7):555-65. PubMed ID: 23512668
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?
Björkman S
Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation.
Sandra L; Smits A; Allegaert K; Nicolaï J; Annaert P; Bouillon T
Br J Clin Pharmacol; 2021 Apr; 87(4):2089-2097. PubMed ID: 33085795
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
